CD161/NK1.1 Antibody (PK136) [DyLight 680]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-08857FR
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Mouse, Human (Negative)
Applications
Flow Cytometry, Immunocytochemistry/ Immunofluorescence
Label
DyLight 680 (Excitation = 692 nm, Emission = 712 nm)
Antibody Source
Monoclonal Mouse IgG2a Kappa Clone # PK136
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
CD Mouse spleen and bone marrow cells enriched for NK-1+ cells
Reactivity Notes
Does not react with Human.
Localization
Cell Surface
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2a Kappa
Applications for CD161/NK1.1 Antibody (PK136) [DyLight 680]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CD161/NK1.1
Alternate Names
Klrb1c, Ly-59, Ly55c
Gene Symbol
Klrb1c
Additional CD161/NK1.1 Products
Product Documents for CD161/NK1.1 Antibody (PK136) [DyLight 680]
Product Specific Notices for CD161/NK1.1 Antibody (PK136) [DyLight 680]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...